WSJ Quotes Elizabeth Gonzalez-Sussman on Illumina’s Possible Divestiture of Grail


Shareholder Activism Practice Vice Chair Elizabeth Gonzalez-Sussman was quoted in a Wall Street Journal (subscription required) article on activist investor Carl Icahn’s proxy contest in an attempt to nominate three people to the board of genetic-sequencing company Illumina and force the company’s divestiture of cancer-detection test maker Grail, which it acquired in August 2021 to the dismay of many investors and before obtaining regulatory clearance. “About 80% of proxy battles generally settle,” Elizabeth notes, “and that is likely to continue given recent SEC rule changes mandating the use of a universal proxy card that might make it easier for dissidents to get one or more of their nominees elected. One potential settlement could include forming a committee, chaired by an Icahn appointee, to oversee a Grail divestiture.” She adds that “Icahn is a prolific activist and I think he’s going to put pressure on the company, and stockholders may push to see a deal getting done.”

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.